SCHEMBL31153489

SCHEMBL31153489

Cc1cc(Br)c[n+](N)c1.Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 6/20 0.38
▸ F2 P00734 3/20 0.36
▸ PRSS1 P07477 3/20 0.36
▸ PRSS2 P07478 3/20 0.36
▸ PRSS3 P35030 3/20 0.36
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ MMP1 P03956 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP8 P22894 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ EDNRB P24530 1/20 0.32
▸ EDNRA P25101 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20874147 0.94 RAPGEF4 (0.40) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL16913904 0.88 RAPGEF4 (0.36) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL23320398 0.87 RAPGEF4 (0.35) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL1900032 0.84 RAPGEF4 (0.44) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL29504768 0.84 RAPGEF4 (0.44) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL3199564 0.81 RAPGEF4 (0.38) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL25283314 0.80 F2 (0.37) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL27225358 0.79 RAPGEF4 (0.36) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL28628697 0.78 RAPGEF4 (0.35) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL28409023 0.78 F2 (0.41) RAPGEF4F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 — — WO disclosed
Send feedback